Table of Contents
Advances in Pharmaceutics
Volume 2015 (2015), Article ID 704946, 12 pages
http://dx.doi.org/10.1155/2015/704946
Review Article

A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges

1NCRD’S Sterling Institute of Pharmacy, Mumbai University, Nerul, Navi Mumbai, Maharashtra 400706, India
2SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, Mumbai University, Vile Parle (West), Mumbai, Maharashtra 400 056, India
3Pacific Academy of Higher Education and Research University, Udaipur, Rajasthan 313003, India
4School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK

Received 30 September 2014; Revised 23 December 2014; Accepted 28 December 2014

Academic Editor: Hidetaka Akita

Copyright © 2015 Suvarna P. Phadatare et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Lemp, C. Baudouin, J. Baum et al., “The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop,” Ocular Surface, vol. 5, no. 2, pp. 75–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Delaleu, R. Jonsson, and M. M. Koller, “Sjögren's syndrome,” European Journal of Oral Sciences, vol. 113, no. 2, pp. 101–113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. “Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international dry eye workshop (2007),” The Ocular Surface, vol. 5, no. 2, pp. 108–152, 2007. View at Publisher · View at Google Scholar
  4. M. Uchino, Y. Uchino, M. Dogru et al., “Dry eye disease and work productivity loss in visual display users: the Osaka study,” The American Journal of Ophthalmology, vol. 157, no. 2, pp. 294–300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Grubbs Jr., S. Tolleson-Rinehart, K. Huynh, and R. M. Davis, “A review of quality of life measures in dry eye questionnaires,” Cornea, vol. 33, no. 2, pp. 215–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Paulsen, K. J. Cruickshanks, M. E. Fischer et al., “Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life,” American Journal of Ophthalmology, vol. 157, no. 4, pp. 799–806, 2014. View at Publisher · View at Google Scholar
  7. B. Miljanović, R. Dana, D. A. Sullivan, and D. A. Schaumberg, “Impact of dry eye syndrome on vision-related quality of life,” American Journal of Ophthalmology, vol. 143, no. 3, pp. 409.e2–415.e2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Tong, S. Waduthantri, T. Y. Wong et al., “Impact of symptomatic dry eye on vision-related daily activities: the Singapore malay eye study,” Eye, vol. 24, no. 9, pp. 1486–1491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. A. Schaumberg, R. Dana, J. E. Buring, and D. A. Sullivan, “Prevalence of dry eye disease among US men: estimates from the physicians' health studies,” Archives of Ophthalmology, vol. 127, no. 6, pp. 763–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Sharma and H. B. Hindman, “Aging: a predisposition to dry eyes,” Journal of Ophthalmology, vol. 2014, Article ID 781683, 8 pages, 2014. View at Publisher · View at Google Scholar
  11. S. E. Moss, R. Klein, and B. E. K. Klein, “Prevalance of and risk factors for dry eye syndrome,” Archives of Ophthalmology, vol. 118, no. 9, pp. 1264–1268, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. C. Pflugfelder, “Prevalence, burden, and pharmacoeconomics of dry eye disease,” The American Journal of Managed Care, vol. 14, no. 3, supplement, pp. S102–S106, 2008. View at Google Scholar
  13. O. D. Schein, B. Munuz, J. M. Tielsch, K. Bandeen-Roche, and S. West, “Prevalence of dry eye among the elderly,” The American Journal of Ophthalmology, vol. 124, no. 6, pp. 723–728, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Smith, J. Albenz, C. Begley et al., “The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international Dry Eye WorkShop (2007),” Ocular Surface, vol. 5, no. 2, pp. 93–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Lemp, “Advances in understanding and managing dry eye disease,” The American Journal of Ophthalmology, vol. 146, no. 3, pp. 350.e1–356.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Schaumberg, D. A. Sullivan, and M. R. Dana, “Epidemiology of dry eye syndrome,” Advances in Experimental Medicine and Biology, vol. 506, pp. 989–998, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Schaumberg, J. E. Buring, D. A. Sullivan, and M. Reza Dana, “Hormone replacement therapy and dry eye syndrome,” The Journal of the American Medical Association, vol. 286, no. 17, pp. 2114–2119, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. S. S. Kassan and H. M. Moutsopoulos, “Clinical manifestations and early diagnosis of Sjögren syndrome,” Archives of Internal Medicine, vol. 164, no. 12, pp. 1275–1284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Fujita, T. Igarashi, T. Kurai, M. Sakane, S. Yoshino, and H. Takahashi, “Correlation between dry eye and rheumatoid arthritis activity,” The American Journal of Ophthalmology, vol. 140, no. 5, pp. 808–813, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. C. Sacca, A. Poscotto, G. M. Venturino et al., “Prevalence and treatment of Helicobacter pylori in patients with blepharitis,” Investigative Ophthalmology & Visual Science, vol. 47, pp. 501–508, 2006. View at Google Scholar
  21. C. Blehm, S. Vishnu, A. Khattak, S. Mitra, and R. W. Yee, “Computer vision syndrome: a review,” Survey of Ophthalmology, vol. 50, no. 3, pp. 253–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Lang and R. E. Roehrs, “Ophthalmic preparations,” in Remington: The Science and Practice of Pharmacy, D. B. Troy, Ed., vol. 1, pp. 850–854, Lippincott Williaims Wilkins, Philadelphia, Pa, USA, 21st edition, 2005. View at Google Scholar
  23. J. Lakshmi Prabha, “Tear secretion—a short review,” Journal of Pharmaceutical Sciences and Research, vol. 6, no. 3, pp. 155–157, 2014. View at Google Scholar · View at Scopus
  24. E. Peters and K. Colby, “The tear film,” in Foundation Volume 2: Physiology of the Eye and Visual System, W. Tasman and E. A. Jaeger, Eds., Duane's Foundations of Clinical Ophthalmology, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2006, Duanes Ophthalmology on CD rom. View at Google Scholar
  25. M. A. Lemp, “Report of the national eye institute/industry workshop on clinical trials in dry eyes,” CLAO Journal, vol. 21, no. 4, pp. 221–232, 1995. View at Google Scholar · View at Scopus
  26. S. Agarwal, A. Agarwal, D. J. Apple, L. Buratto, and J. L. Alió, “Tear film physiology,” in Textbook of Ophthalmology: Basic Sciences Optics and Refraction Neuro-Ophthalmology Strabismus, J. P. Vij, Ed., vol. 1, pp. 39–45, Jaypee Brothers Medical Publishers, New Delhi, India, 1st edition, 2002. View at Google Scholar
  27. J. P. Craig and A. Tomlinson, “Importance of the lipid layer in human tear film stability and evaporation,” Optometry and Vision Science, vol. 74, no. 1, pp. 8–13, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. McCulley and W. E. Shine, “The lipid layer of tears: dependent on meibomian gland function,” Experimental Eye Research, vol. 78, no. 3, pp. 361–365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. H. M. Tabery, “The mucus in the preocular tear film,” in Keratoconjunctivitis Sicca and Filamentary Keratopathy: In Vivo Morphology in the Human Cornea and Conjunctiva, H. M. Tabery, Ed., pp. 1–14, Springer, Berlin, Germany, 2012. View at Google Scholar
  30. J. M. Tiffany, “Tears in health and disease,” Eye, vol. 17, no. 8, pp. 923–926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. E. Johnson and P. J. Murphy, “Changes in the tear film and ocular surface from dry eye syndrome,” Progress in Retinal and Eye Research, vol. 23, no. 4, pp. 449–474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Tsuji and K. Kawazu, “Biomarker identification of tear fluid,” Metabolomics, vol. 2, article 105, 2012. View at Google Scholar
  33. S. A. Mengi and S. G. Deshpande, “Ocular drug delivery,” in Controlled and Novel Drug Delivery, N. K. Jain, Ed., pp. 82–90, CBS Publishers and Distributors, New Delhi, India, 1997. View at Google Scholar
  34. C. Snyder and R. J. Fullard, “Clinical profiles of non dry eye patients and correlations with tear protein levels,” International Ophthalmology, vol. 15, no. 6, pp. 383–389, 1991. View at Publisher · View at Google Scholar · View at Scopus
  35. M. E. Stern, J. Gao, K. F. Siemasko, R. W. Beuerman, and S. C. Pflugfelder, “The role of the lacrimal functional unit in the pathophysiology of dry eye,” Experimental Eye Research, vol. 78, no. 3, pp. 409–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. E. Stern and S. C. Pflugfelder, “Inflammation in dry eye,” Ocular Surface, vol. 2, no. 2, pp. 124–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. J. I. Prydal, P. Artal, H. Woon, and F. W. Campbell, “Study of human precorneal tear film thickness and structure using laser interferometry,” Investigative Ophthalmology & Visual Science, vol. 33, no. 6, pp. 2006–2011, 1992. View at Google Scholar · View at Scopus
  38. J. Y. Niederkorn and H. J. Kaplan, “Immune response and the eye,” Chemical Immunology and Allergy, vol. 92, pp. 176–184, 2007. View at Publisher · View at Google Scholar
  39. J. Y. Niederkorn, “Regulatory T cells and the eye,” Chemical Immunology and Allergy, vol. 92, pp. 131–139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Driver and M. A. Lemp, “Meibomian gland dysfunction,” Survey of Ophthalmology, vol. 40, no. 5, pp. 343–367, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Guzey, I. Ozardali, E. Basar, G. Aslan, A. Satici, and S. Karadede, “A survey of trachoma: the histopathology and the mechanism of progressive cicatrization of eyelid tissues,” Ophthalmologica, vol. 214, no. 4, pp. 277–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. R. W. Yee, H. G. Sperling, A. Kattek et al., “Isolation of the ocular surface to treat dysfunctional tear syndrome associated with computer use,” Ocular Surface, vol. 5, no. 4, pp. 308–315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Versura, P. Nanni, A. Bavelloni et al., “Tear proteomics in evaporative dry eye disease,” Eye, vol. 24, no. 8, pp. 1396–1402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. V. D. Wagh and D. U. Apar, “Cyclosporine a loaded PLGA nanoparticles for dry eye disease: in vitro characterization studies,” Journal of Nanotechnology, vol. 2014, Article ID 683153, 10 pages, 2014. View at Publisher · View at Google Scholar
  45. W. E. Shine and J. P. McCulley, “Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality,” Archives of Ophthalmology, vol. 116, no. 7, pp. 849–852, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. G. N. Foulks, K. K. Nichols, A. J. Bron, E. J. Holland, M. B. McDonald, and J. Daniel Nelson, “Improving awareness, identification, and management of meibomian gland dysfunction,” Ophthalmology, vol. 119, no. 10, supplement, pp. S1–S12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Ohashi, R. Ishida, T. Kojima et al., “Abnormal protein profiles in tears with dry eye syndrome,” The American Journal of Ophthalmology, vol. 136, no. 2, pp. 291–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Solomon, D. Dursun, Z. Liu, Y. Xie, A. Macri, and S. C. Pflugfelder, “Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease,” Investigative Ophthalmology and Visual Science, vol. 42, no. 10, pp. 2283–2292, 2001. View at Google Scholar · View at Scopus
  49. T. Kaercher and A. Bron, “Classification and diagnosis of dry eye,” in Surgery for the Dry Eye, G. Geerling and H. Brewitt, Eds., vol. 41 of Developments in Ophthalmology, pp. 36–53, 2008. View at Google Scholar
  50. J. Murube, J. Németh, H. Höh et al., “The triple classification of dry eye for practical clinical use,” European Journal of Ophthalmology, vol. 15, no. 6, pp. 660–667, 2005. View at Google Scholar · View at Scopus
  51. S. C. Pflugfelder, S. C. G. Tseng, O. Sanabria et al., “Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation,” Cornea, vol. 17, no. 1, pp. 38–56, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Yokoi and A. Komuro, “Non-invasive methods of assessing the tear film,” Experimental Eye Research, vol. 78, no. 3, pp. 399–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. J. Bron, “Diagnosis of dry eye,” Survey of Ophthalmology, vol. 45, supplement 2, pp. S221–S226, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Petroutsos, C. A. Paschides, K. X. Karakostas, and K. Psilas, “Diagnostic tests for dry eye disease in normals and dry eye patients with and without Sjogren's syndrome,” Ophthalmic Research, vol. 24, no. 6, pp. 326–331, 1992. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Rosenfield, “Computer vision syndrome: a review of ocular causes and potential treatments,” Ophthalmic and Physiological Optics, vol. 31, no. 5, pp. 502–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. B. Abelson, G. W. Ousler III, L. A. Nally, D. Welch, and K. Krenzer, “Alternative reference values for tear film break up time in normal and dry eye populations,” Advances in Experimental Medicine and Biology, vol. 506, pp. 1121–1125, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. L. S. Mengher, A. J. Bron, S. R. Tonge, and D. J. Gilbert, “A non-invasive instrument for clinical assessment of the pre-corneal tear film stability,” Current Eye Research, vol. 4, no. 1, pp. 1–7, 1985. View at Publisher · View at Google Scholar · View at Scopus
  58. A. J. Bron, V. E. Evans, and J. A. Smith, “Grading of corneal and conjunctival staining in the context of other dry eye tests,” Cornea, vol. 22, no. 7, pp. 640–650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Watanabe and M. Tanaka, “Rose bengal staining and expression of mucin-like glycoprotein in cornea epithelium,” Investigative Ophthalmology & Visual Science, vol. 37, p. S357, 1996. View at Google Scholar
  60. D. J. Kim and G. N. Foulks, “Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells,” Cornea, vol. 18, no. 3, pp. 328–332, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. S. C. Pflugfelder, A. Solomon, and M. E. Stern, “The diagnosis and management of dry eye: a twenty-five-year review,” Cornea, vol. 19, no. 5, pp. 644–649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. A. A. Afonso, D. Monroy, M. E. Stern, W. J. Feuer, S. C. G. Tseng, and S. C. Pflugfelder, “Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms,” Ophthalmology, vol. 106, no. 4, pp. 803–810, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Tsubota, M. Kaido, Y. Yagi, T. Fujihara, and S. Shimmura, “Diseases associated with ocular surface abnormalities: the importance of reflex tearing,” British Journal of Ophthalmology, vol. 83, no. 1, pp. 89–91, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. M.-A. Javadi and S. Feizi, “Dry eye syndrome,” Journal of Ophthalmic and Vision Research, vol. 6, no. 3, pp. 192–198, 2011. View at Google Scholar · View at Scopus
  65. A. J. Mackor and O. P. van Bijsterveld, “Tear function parameters in Keratoconjunctivitis sicca with and without the association of Sjogren's syndrome,” Ophthalmologica, vol. 196, no. 4, pp. 169–174, 1988. View at Publisher · View at Google Scholar · View at Scopus
  66. M. A. Lemp, A. J. Bron, C. Baudouin et al., “Tear osmolarity in the diagnosis and management of dry eye disease,” The American Journal of Ophthalmology, vol. 151, no. 5, pp. 792–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Rolando, F. Terragna, G. Giordano, and G. Calabria, “Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study,” Ophthalmologica, vol. 200, no. 4, pp. 170–176, 1990. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Calonge, Y. Diebold, V. Sáez et al., “Impression cytology of the ocular surface: a review,” Experimental Eye Research, vol. 78, no. 3, pp. 457–472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. C. G. Begley, B. Caffery, R. L. Chalmers, and G. L. Mitchell, “Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye,” Cornea, vol. 21, no. 7, pp. 664–670, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. O. D. Schein, J. M. Tielsch, B. Munoz, K. Bandeen-Roche, and S. West, “Relation between signs and symptoms of dry eye in the elderly: a population-based perspective,” Ophthalmology, vol. 104, no. 9, pp. 1395–1401, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. R. M. Schiffman, M. D. Christianson, G. Jacobsen, J. D. Hirsch, and B. L. Reis, “Reliability and validity of the ocular surface disease index,” Archives of Ophthalmology, vol. 118, no. 5, pp. 615–621, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Sahai and P. Malik, “Dry eye: prevalence and attributable risk factors in a hospital-based population,” Indian Journal of Ophthalmology, vol. 53, no. 2, pp. 87–91, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. H. D. Perry and E. D. Donnenfeld, “Dry eye diagnosis and management in 2004,” Current Opinion in Ophthalmology, vol. 15, no. 4, pp. 299–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. K. K. Nichols, G. L. Mitchell, and K. Zadnik, “The repeatability of clinical measurements of dry eye,” Cornea, vol. 23, no. 3, pp. 272–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Garcher, “CA 19-9 ELISA test: a new method for studying mucus changes in tears,” British Journal of Ophthalmology, vol. 82, no. 1, pp. 88–90, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. E. Vaikoussis, P. Georgiou, and D. Nomicarios, “Tear mucus ferning in patients with Sjogren's syndrome,” Documenta Ophthalmologica, vol. 87, no. 2, pp. 145–151, 1994. View at Publisher · View at Google Scholar · View at Scopus
  77. K. K. Nichols, G. N. Foulks, A. J. Bron et al., “The international workshop on meibomian gland dysfunction: executive summary,” Investigative Ophthalmology & Visual Science, vol. 52, no. 4, pp. 1922–1929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Tomlinson, S. Khanal, K. Ramaesh, C. Diaper, and A. McFadyen, “Tear film osmolarity: determination of a referent for dry eye diagnosis,” Investigative Ophthalmology and Visual Science, vol. 47, no. 10, pp. 4309–4315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. M. F. Saettone, D. Monti, M. T. Torracca, and P. Chetoni, “Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations,” Journal of Ocular Pharmacology, vol. 10, no. 1, pp. 83–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. G. J. Berdy, M. B. Abelson, L. M. Smith, and M. A. George, “Preservative-free artificial tear preparations: assessment of corneal epithelial toxic effects,” Archives of Ophthalmology, vol. 110, no. 4, pp. 528–532, 1992. View at Publisher · View at Google Scholar · View at Scopus
  81. W. S. Pray, “Ophthalmic conditions,” in Nonprescription Product Therapeutics, pp. 435–445, Lippincott Williams & Wilkins, Baltimore, Md, USA, 2nd edition, 2006. View at Google Scholar
  82. G. Geerling, S. MacLennan, and D. Hartwig, “Autologous serum eye drops for ocular surface disorders,” British Journal of Ophthalmology, vol. 88, no. 11, pp. 1467–1474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. H. D. Perry, S. Doshi-Carnevale, E. D. Donnenfeld, R. Solomon, S. A. Biser, and A. H. Bloom, “Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction,” Cornea, vol. 25, no. 2, pp. 171–175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. J. P. Gilbard, “Ophthalmic solution with tetracycline for topical treatment of dry eye disease,” Advanced Vision Research EP 1105139 B1, PCT/US 1999/017185, 2004. View at Google Scholar
  85. M. Balaram, D. A. Schaumberg, and M. R. Dana, “Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome,” The American Journal of Ophthalmology, vol. 131, no. 1, pp. 30–36, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. G. N. Foulks, “Pharmacological management of dry eye in the elderly patient,” Drugs and Aging, vol. 25, no. 2, pp. 105–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. S. C. Pflugfelder and M. E. Stern, “Therapy of lacrimal keratoconjunctivitis,” in Dry Eye and Ocular Surface Disorders, S. C. Pflugfelder and W. B. Roger, Eds., pp. 309–320, Marcel Dekker, New York, NY, USA, 2004. View at Google Scholar
  88. O. D. Schein, B. Muñoz, J. M. Tielsch, K. Bandeen-Roche, and S. K. West, “An epidemiologic study of medication use and symptoms of dry eye,” Investigative Ophthalmology and Visual Science, vol. 38, no. 4, p. S213, 1997. View at Google Scholar · View at Scopus
  89. K. S. Kunert, A. S. Tisdale, M. E. Stern, J. A. Smith, and I. K. Gipson, “Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes,” Archives of Ophthalmology, vol. 118, no. 11, pp. 1489–1496, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Matsuda and S. Koyasu, “Mechanisms of action of cyclosporine,” Immunopharmacology, vol. 47, no. 2-3, pp. 119–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. H. D. Perry, R. Solomon, E. D. Donnenfeld et al., “Evaluation of topical cyclosporine for the treatment of dry eye disease,” Archives of Ophthalmology, vol. 126, no. 8, pp. 1046–1050, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. J. P. Gilbard, “Non-toxic ophthalmic preparations and methods of preparing them,” Patent no. EP0205279 B1, 1991.
  93. A. Avramoff, W. Khan, A. Ezra, A. Elgart, A. Hoffman, and A. J. Domb, “Cyclosporin pro-dispersion liposphere formulation,” Journal of Controlled Release, vol. 160, no. 2, pp. 401–406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. E. H. Gokce, G. Sandri, M. C. Bonferoni et al., “Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity,” International Journal of Pharmaceutics, vol. 364, no. 1, pp. 76–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. A. J. Bron and L. S. Mengher, “The ocular surface in keratoconjunctivitis sicca,” Eye, vol. 3, no. 4, pp. 428–437, 1989. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Sommer and N. Emran, “Topical retinoic acid in the treatment of corneal xerophthalmia,” The American Journal of Ophthalmology, vol. 86, no. 5, pp. 615–617, 1978. View at Publisher · View at Google Scholar · View at Scopus
  97. A. M. Al Mahmood and S. A. Al-Swailem, “Essential fatty acids in the treatment of dry eye syndrome: a myth or reality?” Saudi Journal of Ophthalmology, vol. 28, no. 3, pp. 195–197, 2014. View at Publisher · View at Google Scholar
  98. E. S. Rosenberg and P. A. Asbell, “Essential fatty acids in the treatment of dry eye,” Ocular Surface, vol. 8, no. 1, pp. 18–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. B. Miljanović, K. A. Trivedi, M. R. Dana, J. P. Gilbard, J. E. Buring, and D. A. Schaumberg, “The relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women,” American Journal of Clinical Nutrition, vol. 82, no. 4, pp. 887–893, 2005. View at Google Scholar · View at Scopus
  100. S. Rashid, Y. Jin, T. Ecoiffier, S. Barabino, D. A. Schaumberg, and M. R. Dana, “Topical omega-3 and omega-6 fatty acids for treatment of dry eye,” Archives of Ophthalmology, vol. 126, no. 2, pp. 219–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Ludwig, “The use of mucoadhesive polymers in ocular drug delivery,” Advanced Drug Delivery Reviews, vol. 57, no. 11, pp. 1595–1639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Joshi, “Microparticulates for ophthalmic drug delivery,” Journal of Ocular Pharmacology, vol. 10, no. 1, pp. 29–45, 1994. View at Publisher · View at Google Scholar · View at Scopus
  103. C. le Bourlais, L. Acar, H. Zia, P. A. Sado, T. Needham, and R. Leverge, “Ophthalmic drug delivery systems—recent advances,” Progress in Retinal and Eye Research, vol. 17, no. 1, pp. 33–58, 1998. View at Publisher · View at Google Scholar · View at Scopus
  104. R. M. Gilhotra, P. Vishva, and D. N. Mishra, “A comparative review of recently developed particulate drug carrier systems,” Targeted Drug Delivery Systems, vol. 7, no. 3, pp. 1–12, 2009. View at Google Scholar
  105. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. D. Meisner and M. Mezei, “Liposome ocular delivery systems,” Advanced Drug Delivery Reviews, vol. 16, no. 1, pp. 75–93, 1995. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Yanagawa, Y. Mizushima, A. Komatsu, M. Horiuchi, E. Shirasawa, and R. Igarashi, “Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres,” Journal of Microencapsulation, vol. 4, no. 4, pp. 329–331, 1987. View at Publisher · View at Google Scholar · View at Scopus
  108. C. di Tommaso, F. Valamanesh, F. Miller et al., “A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation,” Investigative Ophthalmology and Visual Science, vol. 53, no. 4, pp. 2292–2299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. R. C. Nagarwal, S. Kant, P. N. Singh, P. Maiti, and J. K. Pandit, “Polymeric nanoparticulate system: a potential approach for ocular drug delivery,” Journal of Controlled Release, vol. 136, no. 1, pp. 2–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. G. Savini, P. Prabhawasat, T. Kojima et al., “The challenge of dry eye diagnosis,” Clinical Ophthalmoogy, vol. 2, no. 1, pp. 31–55, 2008. View at Google Scholar
  111. A. J. Bron, A. Tomlinson, G. N. Foulks et al., “Rethinking dry eye disease: a perspective on clinical implications,” Ocular Surface, vol. 12, supplement, no. 2, pp. S1–S31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Peral, C. O. Domínguez-Godínez, G. Carracedo, and J. Pintor, “Therapeutic targets in dry eye syndrome,” Drug News & Perspectives, vol. 21, no. 3, pp. 166–176, 2008. View at Google Scholar · View at Scopus
  113. A. Y. Matsumoto, Y. Ohashi, H. Watanabe, and K. Tsubota, “Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial,” Ophthalmology, vol. 119, no. 10, pp. 1954–1960, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. J. E. Jumblatt and M. M. Jumblatt, “Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva,” Experimental Eye Research, vol. 67, no. 3, pp. 341–346, 1998. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Nakamura, T. Imanaka, and A. Sakamoto, “Diquafosol ophthalmic solution for dry eye treatment,” Advances in Therapy, vol. 29, no. 7, pp. 579–589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. Otsuka Pharmaceutical Company, Acucela and Otsuka pharmaceutical announce the initiation of a phase 3 clinical trial to evaluate rebamipide ophthalmic suspension in patients with dry eye syndrome, http://www.otsuka.co.jp/en/release/2012/0719_02.html.
  117. S. Kinoshita, K. Oshiden, S. Awamura, H. Suzuki, N. Nakamichi, and N. Yokoi, “A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye,” Ophthalmology, vol. 120, no. 6, pp. 1158–1165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. “Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome,” http://www.acucela.com/Read-About-Us/Press-Releases.
  119. A. Dota, Y. Takaoka-Shichijo, and M. Nakamura, “Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models,” Clinical Ophthalmology, vol. 7, pp. 211–217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. B. Colligris and J. Pintor, “Dry eye disease compounds currently under evaluation in clinical trials,” Anales de la Real Academia Nacional de Farmacia, vol. 80, no. 1, pp. 151–178, 2014. View at Google Scholar
  121. C. Semba, “Safety study of lifitegrast to treat dry eye (SONATA),” Clinical Trials Identifier: NCT01636206, https://clinicaltrials.gov/ct2/show/NCT01636206.
  122. M. Ono, E. Takamura, K. Shinozaki et al., “Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study,” The American Journal of Ophthalmology, vol. 138, no. 1, pp. 6–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  123. I. Avni, H. J. Garzozi, I. S. Barequet et al., “Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial,” Ophthalmology, vol. 117, no. 7, pp. 1287–1293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. P. M. Karpecki, “Why dry eye trials often fail,” Review of Optometry, vol. 150, no. 1, p. 50, 2013. View at Google Scholar
  125. H. Lin and S. C. Yiu, “Dry eye disease: a review of diagnostic approaches and treatments,” Saudi Journal of Ophthalmology, vol. 28, no. 3, pp. 173–181, 2014. View at Publisher · View at Google Scholar
  126. B. Colligris, H. A. Alkozi, and J. Pintor, “Recent developments on dry eye disease treatment compounds,” Saudi Journal of Ophthalmology, vol. 28, no. 1, pp. 19–30, 2014. View at Publisher · View at Google Scholar · View at Scopus